scPharmaceuticals Inc.
SCPH
$2.45
-$0.06-2.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -55.35% | -59.45% | -35.44% | -43.14% | -48.79% |
| Total Depreciation and Amortization | -76.36% | -62.54% | 13.94% | 21.44% | 33.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,729.26% | 830.77% | 37.20% | -88.86% | -41.16% |
| Change in Net Operating Assets | -107.12% | -66.16% | -8.59% | 33.31% | -1,706.00% |
| Cash from Operations | -19.06% | -26.08% | -31.32% | -38.33% | -71.34% |
| Capital Expenditure | 47.50% | -1,433.33% | -105.56% | -166.67% | -90.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 46.56% | 212.80% | 308.68% | 262.45% | 143.64% |
| Cash from Investing | 46.75% | 212.70% | 308.21% | 262.20% | 143.54% |
| Total Debt Issued | -- | -1.12% | -- | -- | -- |
| Total Debt Repaid | -- | -400.00% | -- | -- | -- |
| Issuance of Common Stock | 265.18% | -12.39% | -98.39% | -97.85% | -69.05% |
| Repurchase of Common Stock | -- | -207.41% | -207.41% | -207.41% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 4,109.40% | -- | -- | -- |
| Cash from Financing | 371.92% | -28.09% | -99.14% | -98.76% | -80.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 218.06% | 977.93% | -209.52% | -171.93% | -661.74% |